Hartmann M

Faculty of Psychology, UniDistance Suisse, Brig, Switzerland.

5 papers · ORCID

ArticlePsilocybin

Integrating the Mystical Experience Questionnaire Into a Broader Psychometric Framework: English Validation of the Psychedelic Experience Scale and Comparison of Psilocybin and LSD Sessions Across Two Controlled Settings.

Stocker K, Hartmann M, Barrett FS +6

Europe PMC2026
ArticlePsilocybin

The 3D-ASCr scale: A revalidation of the core dimensions of the Altered States of Consciousness Rating Scale 5D(11)-ASC for psychedelic research.

Stocker K, Hartmann M, Schmid Y +10

Europe PMC2026
ArticlePsilocybin

The revival of the psychedelic experience scale: Revealing its extended-mystical, visual, and distressing experiential spectrum with LSD and psilocybin studies.

Stocker K, Hartmann M, Ley L +3

Europe PMC2024
ArticleKetamine

Case report: Maintaining altered states of consciousness over repeated ketamine infusions may be key to facilitate long-lasting antidepressant effects: some initial lessons from a personalized-dosing single-case study.

Reissmann S, Hartmann M, Kist A +2

Europe PMC2023
ArticleKetamine

Buddhist-like opposite diminishing and non-judging during ketamine infusion are associated with antidepressant response: an open-label personalized-dosing study.

Stocker K, Hartmann M, Reissmann S +2

Europe PMC2022